Selective silencing of α-globin by the histone demethylase inhibitor IOX1: A potentially new pathway for treatment of β-thalassemia

dc.contributor.authorMettananda, S.
dc.contributor.authorFisher, C.A.
dc.contributor.authorSloane-Stanley, J.A.
dc.contributor.authorTaylor, S.
dc.contributor.authorOppermann, U.
dc.contributor.authorGibbons, R.J.
dc.contributor.authorHiggs, D.R.
dc.date.accessioned2016-11-25T09:30:04Z
dc.date.available2016-11-25T09:30:04Z
dc.date.issued2017
dc.descriptionIndexed in MEDLINEen_US
dc.identifier.citationHaematologica. 2017; 102(3): e80-e84en_US
dc.identifier.issn0390-6078 (Print)
dc.identifier.issn1592-8721 (Electronic)
dc.identifier.issn0390-6078 (Linking)
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/15252
dc.language.isoen_USen_US
dc.publisherPavia, Italy : Ferrata Storti Foundationen_US
dc.subjectthalassemiaen_US
dc.titleSelective silencing of α-globin by the histone demethylase inhibitor IOX1: A potentially new pathway for treatment of β-thalassemiaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
full-text.pdf
Size:
1.37 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
52 B
Format:
Item-specific license agreed upon to submission
Description: